ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 29 filers reported holding ELEDON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $30,209 | -41.9% | 22,050 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $52,038 | +3.5% | 22,050 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $50,274 | -17.6% | 22,050 | 0.0% | 0.00% | -50.0% |
| Q3 2022 | $61,000 | -28.2% | 22,050 | -36.3% | 0.00% | 0.0% |
| Q2 2022 | $85,000 | -37.5% | 34,630 | 0.0% | 0.00% | -33.3% |
| Q1 2022 | $136,000 | -11.1% | 34,630 | 0.0% | 0.00% | -25.0% |
| Q4 2021 | $153,000 | -28.5% | 34,630 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $214,000 | -32.5% | 34,630 | -13.5% | 0.01% | -40.0% |
| Q2 2021 | $317,000 | +3.3% | 40,052 | +39.6% | 0.01% | -9.1% |
| Q1 2021 | $307,000 | – | 28,692 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $8,280,000 | 0.60% |
| CM Management, LLC | 75,000 | $464,000 | 0.35% |
| BVF INC/IL | 1,363,435 | $8,426,000 | 0.33% |
| Cormorant Asset Management, LP | 1,305,095 | $8,065,000 | 0.33% |
| Ikarian Capital, LLC | 344,578 | $2,129,000 | 0.15% |
| Woodline Partners LP | 781,376 | $4,829,000 | 0.08% |
| Eversept Partners, LP | 114,008 | $704,569 | 0.05% |
| INGALLS & SNYDER LLC | 51,149 | $316,000 | 0.01% |
| Virtu Financial LLC | 18,610 | $115,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 34,630 | $214,000 | 0.01% |